HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyrotoxicosis does not protect against incidental papillary thyroid cancer.

AbstractBACKGROUND:
Thyroid cancer is the 10th most commonly diagnosed cancer in Australia, and many studies have linked thyroid-stimulating hormone (TSH) and papillary thyroid cancer (PTC). Low TSH is thought to be protective against thyroid cancer. Our aim was to evaluate the relationship between thyrotoxicosis, in particular Graves' disease, and the incidence of incidental PTC.
METHODS:
After ethics approval, a review of the thyroid database at Monash University Endocrine Surgery Unit was performed. Data was obtained for the period September 1994 to August 2012 and identified those patients who underwent total thyroidectomy (n = 1,898). Those patients with known or suspected malignancy were excluded from the study (n = 390). The remaining patients (n = 1,508) were divided into 3 groups: Graves' disease (n = 250), toxic multinodular goiter (MNG; n = 295), and nontoxic MNG (n = 963) based on indication for surgery and thyroid status. Data were analyzed for the presence of malignancy in each group.
RESULTS:
Of the 1,508 patients included in the study, 96 (6.4%) had thyroid cancer, and the incidence of PTC was similar between the 3 groups. There were 16 cases (6.4%) in the Graves' group, 48 cases (5%) in the nontoxic MNG group, and 20 cases (6.8%) in the toxic MNG group (P = .41).
CONCLUSION:
The incidence of malignancy, particularly PTC, is similar in patients with Graves' disease, toxic MNG, and nontoxic MNG. This study demonstrates no protective effect of thyrotoxicosis on the incidence of incidental thyroid cancer.
AuthorsJessica Preece, Simon Grodski, Meei Yeung, Michael Bailey, Jonathan Serpell
JournalSurgery (Surgery) Vol. 156 Issue 5 Pg. 1153-6 (Nov 2014) ISSN: 1532-7361 [Electronic] United States
PMID25151553 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Carcinoma (epidemiology)
  • Carcinoma, Papillary
  • Female
  • Graves Disease (epidemiology)
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Retrospective Studies
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms (epidemiology)
  • Thyrotoxicosis (epidemiology)
  • Victoria (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: